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1. Introduction 
1.1 Chapter outline 
Many short peptides (Table 1) selectively permeabilize the bacteria plasma membrane (Fig. 
1), leading to their lyses and death: they are therefore a source of antibacterial molecules, 
and inspiration for novel and more selective drugs. Another class of short (<100 residues) 
membrane proteins called viroporins, because they are coded by viral genes (Table 1), 
permeabilizes the membrane of susceptible cells during infection of by most animal viruses 
(Carrasco, 1995; Fig. 1). The permeabilization leads to host cell lyses and the release of the 
virus mass, replicated at host cell expense, to propagate the infection. Detailed knowledge of 
the permeabilization properties of these proteins would allow to design, for instance, 
selective blockers of these pores, that would contrast the spread of the viral infection. 
In this chapter, the patch-clamp technique is employed to study the mechanism of 
membrane permeabilization induced by the pore-forming peptides, under strict 
physiological conditions. This goal is achieved by recording the ion current through the 
channels formed by these peptides, once inserted in a cell plasma membrane. To avoid 
contamination by the cell membrane currents, all the endogenous current sources must be 
blocked. It has been found that the photoreceptor rod outer segment mechanically isolated 
from the retina of low vertebrates (OS; Vedovato & Rispoli, 2007a; Fig. 2) was the most 
suitable cell to carry on the above studies, because it was possible to fully block all its 
endogenous currents without using any drug (such as TTX, TEA, dihydropyridines, etc.), 
that could obstruct the peptide pores or interfere with the pore formation (Fig. 4). The 
peptides were applied to (and removed from) the extracellular OS side in ~50 ms with a  
computer-controlled microperfusion system, in which every perfusion parameter (as the 
rate of solution flow, the temporal sequence of solution changes or the number of automatic, 
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self-washing cycles) was controlled by a user-friendly interface. This system allowed rapid 
application and removal of ions, drugs and peptides on the cells with a controlled timing, so 
that the ion channel characteristics (as its selectivity, blockade and gating) and the dynamics 
of pore formation could be precisely assessed. On the basis of the electrophysiological 
recordings obtained with representative peptides and with selected analogs, as alamethicin 
F50/5 (Crisma et al., 2007; Vedovato & Rispoli, 2007a; Vedovato et al., 2007; Fig. 5-8), the 
cecoprine-mellitin hybrid peptide (CM15; Milani et al., 2009; Fig. 5-7), and a 20-amino acids 
long fragment of the viroporin poliovirus 2B (Madan et al., 2007; Fig. 9), it will be shown 
that the membrane pore formation occurs according to the barrel and stave, toroidal, and 
carpet model, respectively (Fig. 1), that are the most widely-accepted mechanisms of 
membrane permeabilization. 
When recording large currents (produced for instance by high concentrations of peptides 
and/or highly permeable peptides), it is necessary to minimize series resistance, to reduce 
time constant of charging the cell membrane capacitance and error in membrane potential 
control. A second problem arises from the asymmetry of the plasma membrane: it is 
possible that the permeabilization properties of a particular peptide could be different 
depending upon the side of the membrane to which it is applied. For example, it is 
conceivable that viroporins are optimized to insert in the intracellular face of the plasma 
membrane, because they are synthesized in host cell cytosol. These two problems could be 
circumvented by widening the patch pipette shank, through the calibrated combination of 
heat and air pressure. These pipettes dramatically reduce series resistance, and allow at the 
same time to insert pulled quartz or plastic tubes very close to the pipette tip (Benedusi et 
al., 2011; Goodman et al., 2000; Johnson et al., 2008), making it possible the delivery of large 
molecules to the cytosol with a controlled timing (Fig. 3). Finally, it is presented here a 
simple procedure to consistently attain seals with conventional or pressure polished 
pipettes, made from just one glass type, on a wide variety of cell types, isolated from 
different amphibian, reptilian, fish, and mammalian tissues, and on artificial membranes 
made with many different lipid mixtures. 
1.2 Antimicrobial peptides 
The increasing number of common and emerging cases of infection due to antibiotic-
resistant bacteria, occurring for instance in hospitals and in high frequented spaces, requires 
new and reliable sources of innovative antimicrobials. A promising source of these 
compounds are the pore-forming peptides, that permeabilize the bacterial membrane up to 
a point to induce the lyses and death of the pathogen. These peptides are an evolutionarily 
conserved component of the innate immune response found among all classes of life, and 
they are one of the oldest form of defense against pathogens. This chapter is focused on two 
of them: the F50/5 and the CM15 (Table 1). The former peptide is the major component of 
the neutral fraction of the peptaibol antibiotic alamethicin. The peptaibols (Toniolo et al., 
2001) are members of a group of naturally occurring short peptides produced by fungi of the 
genus Trichoderma, characterized by an N-terminal acyl group, a C-terminal 1,2-
aminoalcohol and a high content of the non-proteinogenic Cα-tetrasubstituted α-amino acid 
Aib (α-aminoisobutyric acid). Key amino acids of the F50/5 peptide sequence were also 
modified to understand their implication on the biophysical characteristics of the pore 
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(Vedovato et al., 2007). The CM15 is a small 15-residue synthetic hybrid peptide, first 
described by Andreu et al. (1992), composed of the first seven residues of the silk moth 
cecropin A and residues 2-9 from the bee venom melittin. 
1.3 Viroporins 
Many RNA viruses encode some 60-120 amino acids integral membrane proteins, called 
viroporins, which are localized primarily within the endoplasmic reticulum and plasma 
membrane of host cells. About a dozen proteins that qualify as viroporins have been 
discovered so far, including poliovirus 2B, alphavirus 6K, HIV-1 Vpu, hepatitis C virus 
(HCV) p7 protein, influenza virus M2, and the coronavirus E (CoVE) protein from the 
severe acute respiratory syndrome (SARS) virus (Gonzalez & Carrasco, 2003). Viroporins are 
not essential for virus replication, but they boost virus growth by taking part in several viral 
functions, and by perturbing several mechanisms of host cell, as glycoprotein and vesicle 
turnover, and plasma membrane permeability. The latter occurs because viroporin 
oligomerization gives rise to hydrophilic pores at the membranes of host cell. These pores 
are thought to play a crucial role for viral infectivity, possibly by causing the lyses and death 
of host cell (letting therefore the replicated virus particles to escape the cell), with a 
mechanism analogous to the bacterial lyses produced by the antimicrobial peptides. This 
chapter is focused on elucidating the mechanism of membrane permeation produced by the 
poliovirus 2B (Table 1). 
1.4 Peptides as bioactive molecules and archetypal ion channel 
Besides the development of anti-bacterial and anti-viral drugs, the pore-forming peptides, 
being the most ancestral form of membrane pores, provide also a simple model system to 
understand the structure-function relationships of channels and the molecular basis of 
peptide/protein oligomerization in lipid membranes. Moreover, these peptides are a powerful 
molecular model on which to build custom molecules with wide-ranging biotechnological 
application, as ion channel modulators (Hille, 2001), anti-tumorigenic agents (Hoskin & 
Ramamoorthy, 2008; Papo & Shai, 2005), biosensors for many different analytes (which could 
deliver a configurable binding site for substrates encoded in a readily measured electrical or 
optical signal; Aili & Stevens, 2010), and provide a pharmacological approach to cure 
channelopaties (reviewed in Wilde, 2008). In the latter case, a synthetic channel could be 
inserted in cells expressing an aberrant ion channel (Wallace et al., 2000) to restore the 
physiological ion flow. Bacterial and viral peptides may finally provide insights about the 
evolution of channel selectivity and gating and, more generally, of ion pumps and exchangers. 
Recent data from many laboratories indicate indeed that secondary transporters are basically 
pores with an highly specialized gate system, rather than proteins with a transport mechanism 
completely different from the ion channels one (reviewed in Gadsby, 2009). 
1.5 Mechanism of membrane permeabilization 
Regardless their origin and purpose, all the membrane permeabilizing peptides adhere first 
parallel to the lipid bilayer (Fig. 1a and b), they then orient perpendicular to the membrane, 
and finally they bind together and/or reorganize the lipid bilayer to form transmembrane 
pores. Because of their amino acid composition, amphipathicity, and cationic charge, three 
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distinct mechanisms have been proposed to explain membrane permeabilization: “barrel 
and stave”, “toroidal”, and “carpet” (Fig. 1; reviewed in Brogden, 2005).  
 
Fig. 1. Mechanisms of permeabilization induced by pore-forming peptides. After adhering 
on the external face of the membrane (a and b), the peptide could insert in the membrane 
according to a barrel and stave (c), toroidal (d and e), or carpet mechanism (f and g). 
The first mechanism requires that the peptide monomers, weekly bound to the membrane 
surface (Fig. 1a), orient perpendicularly to the latter and bind together (as staves) around a 
central pore (the barrel; Fig. 1c). The peptide hydrophobic segments face the bilayer core, 
while their hydrophilic segments face the pore lumen. In the toroidal pore, the polar 
segments of the peptides interact with the polar head groups of the lipids more strongly 
than in the case of the barrel and stave pore, so that the lipids are forced to tilt from the 
lamellar normal up to connect the two leaflets of the membrane, forming a continuous bend 
from one side to the other of the membrane, in the fashion of a toroidal hole (peptides 
spanning the entire membrane: Fig. 1d; peptide shorter than the membrane thickness: Fig. 
1e). Differently from the barrel and stave mechanism, the peptides are always associated 
with the lipid head groups, even when they are perpendicularly inserted in the lipid bilayer. 
In the carpet mechanism, the strong electrostatic interactions between peptides and the 
phospholipid head groups result in the peptide carpeting of the membrane (Fig. 1b). The 
peptides then assemble with the lipids to form transiently toroidal pores (Fig. 1e), allowing 
more and more peptides to cross the bilayer and eventually cover the other membrane 
leaflet. Finally, the peptides may isolate a micelle that detaches from the membrane to head 
to the water phase (Fig. 1g), leading to the bilayer disintegration in a detergent-like manner. 
It is also possible that the contour of a micelle may be delimited by several toroidal pores 
that happen to group together (Fig. 1d), and this micelle may eventually separate from the 
membrane and solubilize (Fig. 1f). Moreover, it is conceivable that the same peptide may 
permeabilize the membrane with one mechanism or with another (Brogden, 2005), 
depending upon the surrounding conditions, as the lipid environment, the temperature, the 
peptide concentration, the presence of some other endogenous or exogenous molecules 
(Noshiro et al., 2010), etc. 
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2. Methods: Studying peptide-induced permeabilization under strict 
physiological conditions 
2.1 Rationale 
Most of the research on the pore-forming peptides has the long-term goal to understand at 
the molecular level how the peptide-lipid interactions produce structural changes in both, 
and optimal peptide orientation, to eventually produce a raise in membrane conductance 
(Chen et al., 2001; Saint et al., 2002). With this aim, a widely used technique consists in 
recording the ion current flowing through the pore formed by these peptides, inserted in an 
artificial lipid bilayer. To have an acceptable signal-to-noise ratio in these experiments, it is 
necessary to apply non-physiological voltages and ionic gradients, that however could affect 
the peptides themselves, or even the membrane in which they were inserted (Bockmann et 
al., 2003). Moreover, to our knowledge, no studies aimed to measure the aggregation time 
course of peptides to form a functioning pore in the plasma membrane of a living cell, and 
the kinetics of their disaggregation. 
In this chapter, the biophysical characteristics and the pore formation dynamics of selected 
antimicrobial peptides and viroporins, and some of their analogues, were studied under 
strict physiological conditions. This was accomplished by inserting these (or other) peptide 
monomers in the plasma membrane of a living cell, and recording the current flowing 
through the peptide channels at a desired voltage by using the whole-cell, voltage-clamp 
technique. To make sure that the entire current was flowing through these channels, it was 
looked for a particular cell system where all the endogenous conductances could be blocked 
without using any drug, that could affect the peptide pore as well. The outer segment of the 
photoreceptor rod (OS) mechanically isolated from low vertebrate retinae (Rispoli et al., 
1993) is such a cell system, because the only channel type of this cell fragment is fully closed 
by bright light. The OS of Rana esculenta have been found particularly suitable to carry on 
this study, because of their large size (Fig. 2a, Inset) and for the commercial availability and 
low cost of this edible frog species. 
To have a precise control of pore formation (and disaggregation), a custom-made, computer 
controlled microperfusion system was employed to rapidly apply (and remove) the peptides 
under study onto a cell (Vedovato & Rispoli, 2007a). Peptide formation and disaggregation 
dynamics were therefore gathered, respectively, from the time course of the development 
and fall of the exogenous current (at a given potential, Vh), following peptide application 
and removal. This system is also capable to apply and remove ions, drugs and peptides on 
any isolated cell or tissue fragment in ~50 ms with an accurately controlled timing. This 
allowed to study in detail the biophysical characteristics of the channels, that are of key 
importance to assess the peptide performances and its potential biotherapeutic activity. 
The pipette tapered shank and the small tip opening give high access resistances (Ra) and 
constitute the dominant barrier to molecular diffusion between pipette and cell cytosol in 
the whole-cell recording configuration (Pusch & Neher, 1988). This shortcoming: 
1. gives errors in membrane potential control, due to the voltage drop across the Ra in the 
presence of large membrane currents; 
2. impedes the precise measure of current onset and offset kinetics, due to the often too 
large time constant of charging the cell membrane capacitance through the Ra; 
www.intechopen.com
 Patch Clamp Technique 
 
334 
3. causes intracellular ion accumulation or depletion, and it slows down the rate of 
exogenous molecules incorporation via the patch pipette. 
It is however possible to enlarge the pipette shank (Goodman et al., 2000; Johnson et al., 
2008), through the calibrated combination of heat and air pressure, with a custom made 
inexpensive set-up (Benedusi et al., 2011). Besides improving the electrical recordings, the 
enlarged tip geometry of the pressure polished pipettes could accommodate pulled quartz 
or plastic perfusion tubes close to the pipette tip, allowing the fast and controlled cytosolic 
incorporation of exogenous molecules. 
Another problem of the patch-clamp recording is to gain consistently tight seals: although 
this technique has been widely used by more than 40 years, little is still known about the 
nature of the molecular interactions underlying the generation of the seal between 
membrane and glass (Suchyna et al., 2009). This problem has been addressed here, and it 
has been found a simple method that allows to consistently attain seals on natural or 
artificial membranes, by using conventional or pressure polished pipettes made from just 
one glass type (Benedusi et al., 2011). 
2.2 OS preparation and view 
OS were mechanically isolated from the retina of Rana esculenta in the dark, using infrared 
illumination and an infrared viewer. Methods are described in detail elsewhere (Vedovato & 
Rispoli, 2007a). The retina was "peeled" from an eyecup piece and was gently triturated in 
Ringer (~5 ml), using a fire-polished Pasteur pipette to obtain the OS; a Ringer drop 
containing the OS was then transferred to the recording chamber placed on the microscope 
(TE 300, Nikon, Tokyo, Japan) stage. The OS were illuminated with an ultrabright infrared 
LED (900 nm) and focused on a fast digital camera (C6790-81, Hamamatsu Photonics, 
Tokyo, Japan) coupled to the microscope. The OS were then viewed in the frame grabber 
window generated by the AquaCosmos software package (version 2.5.3.0; Hamamatsu 
Photonics), which controlled all the camera parameters (as gain, frame rate, binning, etc.) as 
well via a PCI board (PCDIG, Dalsa, Waterloo, ON, Canada). 
2.3 Solutions and electrophysiological recordings 
OS were recorded using the whole-cell configuration of the patch-clamp technique under 
visual control at room temperature (20-22 °C; Fig. 2a, inset). The Ringer solution had the 
following composition (in mM): 115 NaCl, 3 KCl, 10 HEPES free acid [N-(2-
hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid)], 0.6 MgCl2, 0.6 MgSO4, 1.5 CaCl2, 10 
glucose (osmolality 260 mOsm/Kg, buffered to pH = 7.6 with NaOH). All chemicals were 
purchased from Sigma (St. Louis, MO, USA). 
The current amplitude (recorded employing an Axopatch 200B; Molecular Devices, 
Sunnyvale, CA, USA) elicited by repetitive -10 mV pulses was used to measure the seal 
resistance during cell-attached recording. Once the whole-cell recording configuration was 
obtained, the current transients produced by these repetitive pulses were used to measure 
the OS membrane resistance (Rm), the access resistance (Ra), and the membrane capacitance 
(Cm). Peptides (whose primary sequence are reported in Table 1) were applied and removed 
in ~50 ms by switching forth and back the OS from a stream of control solution [composition 
(in mM): 130 KCl, 1 CaCl2 and 10 HEPES; osmolality 260 mOsm/Kg, buffered to pH=7.6 
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with KOH] to a stream of control solution containing the peptide under test (see paragraph 
2.5). Patch pipettes were filled with control solution as well in order to drive the current just 
with the holding potential (Vh, that was typically –20 mV). 
The stability of the recording was checked by routinely measuring Rm, Ra, and Cm in control 
perfusion solution, i.e. before and after each peptide application. Recordings were filtered at 
2 kHz via an eight-pole Butterworth filter (VBF/8 Kemo, Beckenham, UK), sampled on-line 
at 5 kHz by a Digidata 1322A (Molecular Devices) connected to the SCSI port of a Pentium 
computer running the pClamp 9.0 software package (Molecular Devices), and stored on 
disk. Data were further low-pass filtered off-line at 200 or 500 Hz using a Gaussian filter, or 
by using the “running average” routine of SigmaPlot (version 8.0; Jandel Scientific, San 
Rafael, CA, USA), and analyzed using Clampfit (version 9.0; Molecular Devices). Figures 
and statistics were performed using SigmaPlot; results are given as means±SEM. 
2.4 Peptide sequences and usage 
The primary structure of all peptides studied in this chapter is reported in Table 1. CM15 
and its scrambled version were dissolved in bi-distilled water, F50/5 and its analogs in 
methanol, and the peptide fragments of poliovirus 2B in dimethyl sulfoxide (DMSO), to get 
a 50, 100, 500, and 1000 μM stock solutions; an aliquot of one of these peptide stocks was 
dissolved in the perfusion solution to get a final peptide concentration of 0.25, 0.33, 0.1, 1, 
2.5, 5 and 10 μM, and used within 30 min. Control experiments proved that the methanol 
and DMSO contamination of the perfusion solution (no larger than 10 nl/ml and 1 μl/ml, 




[L-Glu(OMe) 18,19] Ac-UPUAUAQUVUGLUPVUUEE-Phol 
[L-Glu(OMe) 7,18,19] Ac-UPUAUAEUVUGLUPVUUEE-Phol 
CM15 Ac-KWKLFKKIGAVLKVL-NH2 





Table 1. Residue sequences of the peptides studied here. Ac, acetyl; Phol, phenylalaninol. 
CM15 and its scrambled version were a generous gift of Dr. Feix of Department of 
Biophysics, Medical College of Wisconsin, Milwaukee, WI, USA; F50/5 and its analogs were 
synthesized in the lab of Dr. Toniolo of Department of Chemistry of the University of 
Padua, Italy (Peggion et al., 2004); the peptide fragments of poliovirus 2B were synthesized 
in the lab of Dr. Nieva of Unidad de Biofísica (CSIC-UPV/EHU), Universidad del País 
Vasco, Bilbao, Spain (Madan et al., 2007). 
2.5 Fast perfusion system 
After obtaining the whole-cell recording, the OS was aligned in front of a multibarreled 
perfusion pipette of a fast microperfusion system (Fig. 2a). The perfusion pipette was moved 
on a horizontal plane with a precision step motor, controlled by a user-friendly interface 
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Fig. 2. The technique employed to investigate the permeabilization properties of the 
peptides inserted in a natural membrane. a, a whole-cell recorded OS (shown enlarged in 
the inset; scale bar is 20 µm) aligned in front of the perfusion pipette (scale bar is 500 µm; 
horizontal orange arrows denote perfusion flows). b, trace shows the current jump upon 
switching an open patch pipette filled with 130 mM K++1 mM Ca2+ (9 MΩ, Vh=0 mV) from 
65 mM choline+65 mM K++1 mM Ca2+ to 130 mM K++1 mM Ca2+. The two latter solutions 
had a 0.6 mV junction potential, producing a current jump of 70 pA, lasting ~50 ms, that had 
the same kinetics of the solution change. This kinetics is also shown by the three still frames 
(650x494 pixels at 12 bits grey-scale resolution), extracted from a 30 frame/s movie 
synchronized with the voltage-clamp recording. The boundary separating the two solution 
streams was clearly visible, allowing a precise electrical and visual correlation of the 
solution change dynamics. c, user interface of the perfusion apparatus. d, scheme of one 
perfusion line (composed by a syringe, a three-way valve, a cylinder and one perfusion 
pipette barrel) and perfusion flow (in orange) during syringe refilling (upper panel) and 
during perfusion of an OS recorded in whole-cell (lower panel); drawing not in scale. 
(Fig. 2c) running in a host computer, connected to the microperfusion system via the serial 
port. The perfusion pipette was constituted of up to six barrels (500 µm of side; two barrels 
of a four barrelled pipette are visible in Fig. 2a) made with precision, square glass capillaries 
glued together. Peptides were applied and removed in ~50 ms (see below) by moving the 
perfusion pipette so that to switch the whole-cell recorded OS back and forth from a stream 
of control perfusion solution (usually containing 130 mM of a monovalent cation and 1 mM 
Ca2+; see Results) to a stream containing the peptide (dissolved in the same perfusion 
solution). This strategy allowed to assess the dynamics of the pore formation and the 
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possible reversibility of the process. The temporal lag between the time in which the 
command (internal or triggered by an external device) moving the perfusion pipette was 
imparted, and the time in which the solution change effectively occurred, as well as the 
speed of the solution change, were occasionally measured (since they were very 
reproducible) as illustrated in Fig. 2b. At the end of experiment, the cell was blown off the 
patch pipette with a positive pressure pulse, and the odd perfusion lines were filled with a 
solution having 50% choline chloride and 50% KCl, while the even perfusion lines were 
filled with the patch pipette solution. The choline chloride had a different refraction index in 
respect to all the patch pipette solutions used, therefore the boundary separating two 
adjacent streams was clearly visible (see the three still frames of Fig. 2b). Since a junction 
potential was also developed between the two solutions, upon repeating the solution 
changes previously performed with the OS, a current jump was recorded by the open 
pipette (voltage-clamped at 0 mV) that had the same kinetics of the solution change (Fig. 2b). 
By comparing the electrical and the imaging recordings, it results that the solution change 
was completed within the 50 ms necessary to the OS to cross the boundary separating two 
adjacent streams. 
The perfusion system could be also used to apply solutions to the cell of different ionic 
composition or containing a specific drug, so that to study, besides the current-to-voltage 
characteristics, the ion selectivity and blockade of the pore as well. To this aim, all perfusion 
solutions contained the peptide under study at the same concentration, so that to compare 
the effects of the test solutions at a constant membrane permeabilization. 
The solutions flowing in the perfusion pipette were fed by means of precision syringes 
(Hamilton, Reno, NV, USA), whose piston was moved by a DC motor controlled via the 
computer interface (Syringe motor controller panel, Fig. 2c). The typical perfusion speed was 
15 μl/min, therefore minimal amounts of peptide solution (<500 μl) were required to 
perform peptide applications lasting more than half an hour. The fine regulation of the 
perfusion flow speed and of the velocity of perfusion pipette horizontal movements 
(controlled by the Velocity button in the Channel Controller panel) allowed to perform fast 
solution changes on practically any isolated cell type, or even on small cell aggregates, 
without any significant change of the seal resistance. This system has been successfully 
tested on cells mechanically or enzymatically isolated from different amphibian, reptilian, 
fish, and mammalian tissues, on cultured cells and on giant unilamellar vesicles made with 
many different lipid mixtures. Depending upon the position of the six three-way solenoid 
valves (Fig. 2d; all tubing and valve components in contact with the solutions were made in 
teflon), each one independently controlled by the Valve controller panel (Fig. 2c), the solution 
contained in each syringe could be sent to the perfusion pipette (symbolized by the 
perfusion pipette in the Valve controller panel; Fig. 2c) or redirected to one of the six 
reservoirs (in which each solution was made, symbolized by a group of cylinders in the 
Valve controller panel). This allowed to save the solutions that were not used, or to avoid 
that, upon switching between two non-adjacent barrels, the OS was transiently exposed to a 
third undesired solution. Once emptied, the syringes could be refilled from the cylinders by 
clicking on the Refill button (in the Syringe motor controller panel, Fig. 2c). This command 
moved the six three-way valves in the cylinder position and backed up the DC motor at full 
speed until the syringes were filled: the motor was then stopped by an end-position switch; 
a second end-position switch stopped the motor when syringes were emptied (the status of 
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the switches was signaled by the End switch rear and the End switch front indicators in the 
Syringe motor controller panel, that turned from green to red). When particularly precious 
solutions were used, all the perfusion lines were filled with control solution and the 
connectors to the perfusion pipette were detached and immersed in the vials containing the 
precious solutions. The syringe motor was then backed up and these solutions filled just the 
terminal portion of the tube between the valve and the perfusion pipette. The connectors 
were replaced and the motor was started in the forward direction for just enough time to fill 
the pipette barrels; at this point the perfusion pipette was brought in the recording chamber 
and the experiment was initiated. At the end of the experiment, all the perfusion lines could 
be washed by dipping all the tubes previously dipped in the cylinders (or in the vials), into a 
container filled with distilled water (or other washing solution, as methanol, ethanol, 
DMSO, etc.), and clicking the Wash button in the Syringe motor controller panel. This 
command activated the valves and moved the motor back and forth at full speed, so that the 
syringes were emptied through the perfusion pipette and refilled with the wash solution, a 
number of times set by the user in a sub-window opened by the Wash button (not shown). 
The timing and sequence of the solution changes (i.e. the direction, speed and travel of the 
perfusion pipette step motor), the syringe motor speed, start, stop and direction, and each 
valve position could be also automatically controlled by simple instructions, entered as a 
text code (visible in white characters in the black window of Fig. 2c). A set of instructions of 
arbitrary length could be manually executed in sequence by clicking on the TRIGGER 
button; each instruction could be executed after an arbitrary delay set by a particular 
instruction, that would therefore set the sequence timing. Every instruction could be also 
executed after receiving a trigger pulse from an external device, allowing, for example, the 
synchronization of the solution changes with the pClamp voltage protocols (as in the 
experiments shown in Fig. 5-9) or with an imaging system (as in the experiments of Fig. 2b). 
It was also possible to send out a trigger pulse, after executing a set of instruction of 
arbitrary length, to synchronize other external devices. 
2.6 Pressure polish pipette 
Patch pipettes were pulled in the conventional manner from 50 or 100 µl borosilicate glass 
microcaps (Drummond, Broomall, PA, USA), with a vertical puller (model PP-830, 
Narishige, Tokyo, Japan), and tightened into a pipette holder. The latter was clamped to the 
microscope stage, and a three-way valve allowed to connect the pipette to a pressurized air 
line (set to ~4 atm and filtered to 0.2 µm to avoid pipette clogging), or to vent it to air. The 
pipette holder was moved by means of the XY manipulator of the microscope stage, to 
center the pipette tip into the central bend of an “omega” shaped, glass-coated platinum 
filament (50 µm of diameter; Fig. 3a and b). This shape ensured the homogeneous softening 
of the pipette shank, when the filament was heated by passing a constant current through it. 
To avoid metal evaporation onto the pipette, the filament was uniformly glass-coated by 
dipping it in borosilicate glass powder when heated to yellow color. The filament was tin 
soldered to a copper holder (that functioned also as a heat sink, Fig. 3a) mechanically 
coupled to a micromanipulator, and electrically connected to a variable current generator 
via a “push-to-make” switch. To produce the adequate heat to soften the pipette tip (i.e. the 
filament was brought to reddish color), the current was typically set to ~1.2 A for filaments 
shaped as shown in Fig. 3a. The pressure polishing set-up was enclosed in a box, to protect 
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the filament from air currents, that could strongly affect the filament temperature as well, 
and the entire set-up from dust. The optical field containing the filament and the pipette was 
viewed on an LCD monitor connected to a contrast-intensified CCD camera (VX 44, Till 
Photonics, Gräfelfing, Germany), that replaced the objective turret of a bright-field 
stereomicroscope (YS2-T, Nikon). The video signal was also digitized on-line (by Pinnacle 
Studio MovieBox DV, Avid, Burlington, MA, USA) and stored on a computer, to have a 
record of the pipette shaping process. 
 
Fig. 3. Filament shape, pipette alignment, and controlled intracellular perfusion. a, the glass-
coated platinum filament tin soldered to the holder; scale bar is 5 mm. The “omega” shaped 
region of the filament within the white box is enlarged in b, where it is also shown a pipette 
before pressure polishing, correctly aligned with the filament; scale bar: 100 µm. c, a pulled 
quartz tube is positioned inside the lumen of a conventional pipette as close as possible to its 
tip; d, the same tube is inserted in a pressure polished pipette. Scale bar is 20 µm in c and d. 
3. Results and discussion 
3.1 OS endogenous conductances and peptide characterization 
The vertebrate OS possesses just two endogenous conductances: the main one is the light 
sensitive (or cGMP) channel, the other one is the Na+:Ca2+,K+ exchanger (reviewed in 
Rispoli, 1998). If the OS is illuminated, the light sensitive channels close, while the exchanger 
can be blocked if just one of the ion species transported by it (i.e. Na+, Ca2+ or K+) is 
removed from both sides of the membrane (Vedovato & Rispoli, 2007b). To simplify the 
interpretation of the experiments, patch pipettes were filled with the same perfusion 
solution (that typically contained 130 mM of KCl or 130 mM of NaCl) to ensure the current 
through the exogenous peptide pore was only driven by the holding potential (Vh, usually 
set to -20 mV). To preserve the membrane integrity during long recordings, it was necessary 
to include a physiological concentration of Ca2+ (1 mM) to the external solution (Vedovato & 
Rispoli, 2007a). Therefore, 1 mM Ca2+ was added to the intracellular solution as well, to 
www.intechopen.com
 Patch Clamp Technique 
 
340 
ensure that the current was still entirely driven by Vh. Under these ionic conditions and 
under room lights (that will close all the light-regulated channels), the OS membrane 
resistance (Rm) was usually larger than 1 GΩ in the absence of the peptide, exhibiting a 
linear (ohmic) current-to-voltage characteristic (Fig. 4). 
 
Fig. 4. Electrical properties of OS. Central panel: average whole-cell current recorded from a 
representative OS under room lights (pipette and external solution: 130 mM K++1 mM Ca2+), 
subjected to 5 s voltage steps from –80 mV to +80 mV in 10 mV increments (top panel) 
starting from Vh=0 mV and repeated 10 times; lower panel, the average current recorded for 
each voltage step shown in the central panel is plotted against the voltage step (the resulting 
current-to-voltage characteristic is linear, giving Rm~8 GΩ). 
The high signal to noise ratio, given by the large value of Rm, allowed the detection of 
current signals down to the single channel level. The dynamics of the pore formation was 
tested by means of the following protocol (shown in Fig. 5a, 6b, 7a, 8a, 9a and c). With the 
isolated OS continuously held to Vh, Rm was measured before peptide perfusion by means 
of a brief -10 mV step (indicated with an asterisk in all figures); the peptide was then 
quickly applied (in about ~50 ms) using the fast perfusion system. Once the current had 
stabilized, the OS was finally returned to the control solution (without the peptide) to 
assess the possible recovery of the current, and Rm was again measured. In control 
solution, repetitive 10 mV pulses were routinely applied to check that Ra was unchanged, 
otherwise the cell was discarded. 
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In general, the waveform of the current induced by a peptide application and withdrawal 
can be described quantitatively by the following five kinetics parameters: 
1. The activation delay (Da), defined as the time lag between peptide application and the 
time in which the current deviates from its baseline (following peptide application), 
more than three times the noise average fluctuation (indicated by the arrows in Fig. 7c 
and e, 8b, and 9b); 
2. The activation time constant (τa), defined as the time constant of the single exponential 
fit to current activation (Fig. 7a and b, black traces); 
3. The current amplitude at steady-state (Imax); 
4. The deactivation delay (Dd), defined as the time lag between peptide removal and the 
time in which the current deviates from Imax more than three times the noise average 
fluctuation; 
5. The deactivation time constant (τd) defined as the time constant of the single 
exponential fit to current deactivation (Fig. 7a and b, black traces).  
To avoid errors produced by the noise, the above parameters were measured on the low-
pass filtered or on the smoothed traces (see Methods). 
3.2 Comparison between CM15 and F50/5 permeabilization properties 
Application of CM15 at concentrations ≤1 µM gave no detectable macroscopic currents nor 
single channel events, but currents were routinely obtained at concentrations ≥2.5 µM (Fig. 5, 
6a, 7a, c, and d). Occasionally, at early times of peptide application at low concentration, 
current waveform resembled (barely) single channel events (the clearest recording ever 
 
Fig. 5. Membrane permeabilization induced by CM15 at early times of recording at low 
concentrations. a, application for 16 s (grey thick line) and withdrawal of CM15 at 
concentration of 2.5 µM on an OS recorded in whole-cell configuration. The membrane 
resistance was checked before and after peptide application by means of -10 mV pulses, 
indicated by the asterisks; holding potential was -20 mV throughout the recording. b, 
enlargements of the recording of a 6.6 s after the perfusion onset (upper panel) and just after 
peptide removal from external solution (lower panel). To identify the temporal location of the 
two enlargements, timing of panels in b follows the one of panel a. 
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obtained is shown in Fig. 5). These events were followed by a noisy macroscopic current, 
that was expected to flow through several pores, which number was progressively 
increasing up to a steady-state number, as the peptide was continuously applied. It can be 
argued that the mechanism of pore formation by CM15 occurs according to a barrel and 
stave model: this requires that a certain number of monomers binds together once in the 
plasma membrane to form an ion conductive pore (Fig. 1). If the number of peptide  
 
Fig. 6. Comparison between the currents elicited by repetitive applications of CM15 and 
F50/5. a, repetitive applications of CM15 at concentration of 5 µM (thick grey lines); Vh was -
20 mV but at the thick black lines, where it was +20 mV; dotted line indicates the zero current 
at the beginning of recording (i.e. before any peptide application). b, repetitive applications 
of F50/5 at concentration of 1 µM at -20 mV. In both panels, the clipped vertical lines, 
indicated by the symbol , are actually the response to quick voltage ramps (see text) used 
to construct the current-to-voltage relationships (shown in Fig. 7d); the membrane resistance 
was checked before and after peptide application by means of -10 mV pulses, indicated by 
the asterisks; Vh was -20 mV throughout the recording. The blanks in the recordings in 
control solution in a and b omit the repetitive voltage pulses used to measure Rm, Cm and Ra 
and/or the response to voltage ramps (a representative one is shown in Fig. 7d,  
thick black trace). 
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monomers inserted in the membrane is small, as it occurs at early times of peptide 
application at low concentration, the pores are formed and disaggregated frequently, 
producing single channel events. However, besides the rarity of the occurrence of these 
events at early time of the recordings, they were never detected just after peptide removal, 
as instead expected, since the number of peptide monomers inserted in the membrane 
should return to be small again. At difference with CM15, low concentrations of F50/5 (and 
of their analogs reported in Table 1) gave clear and sustained single channel events (Fig. 8c; 
Vedovato & Rispoli, 2007a). Incidentally, these channel events were produced by F50/5 at 
concentrations as low as 250 nM, showing a much larger efficiency in pore formation in 
eukaryotic cell membrane in respect to CM15. 
The CM15 application at concentration of 5 µM gave consistently macroscopic currents (Fig. 
6a) that developed exponentially to a relatively stable level (Fig. 7a). This level was not 
however maintained if the peptide application was lengthen, but current kept slowly 
increasing throughout the peptide application (Fig. 6a and 7a), at difference with sustained 
F50/5 perfusion (Fig. 7b), that produced very stable current. Moreover, repetitive CM15 
applications produced currents of increasingly amplitude (Fig. 6a), but no such increase was 
ever observed with F50/5 (Fig. 6b). This again excludes that CM15 permeabilizes the plasma 
membrane according to a barrel and stave mechanism, since during continuous peptide 
application at high concentration, membrane peptides are expected to equilibrate with the 
ones externally perfused, giving a stable macroscopic current, as in the case of F50/5. 
Moreover, the current did not return to the zero level following peptide removal (Fig. 6a and 
7a), but it recovered to a plateau level, where Rm was consequently smaller in respect to the 
one measured before the peptide application. The CM15 concentration was larger, and/or 
more and more applications were performed (i.e. the larger was the current induced by 
CM15), the larger was the plateau amplitude and the smaller was the Rm (measured during 
the plateau phase). This is again in contrast to F50/5, where current and Rm fully recovered 
(Fig. 6b and 7b) following peptide removal. In these experiments, the F50/5 and CM15 
concentrations were selected to give currents smaller than 1 nA, since there is a voltage error 
induced by Ra (that was typically ~10 MΩ in the recordings considered in this chapter) that 
can be as high as 10 mV at 1 nA of current. 
The kinetics parameters of current activation and deactivation defined in paragraph 3.1 can 
be measured from the fittings and the interpolations to the recordings as illustrated in Fig. 
7a, b, c and e. However, these parameters cannot be unambiguously estimated in the case of 
CM15, since they depend by the current amplitude. For instance, from the first exposure to 
the last one of Fig. 6a, Da progressively decreased from 2.6 s to 0.5 s and τd increased from 3.4 
to 26.1 s, as the current increased from 50 pA to about 1 nA. To obtain a reproducible value 
of the kinetics parameters of the CM15-induced current, in order to compare them with the 
ones obtained with F50/5, CM15 recordings were selected to approximately give current 
amplitudes comparable to the ones induced by 1 µM F50/5, irrespective of the CM15 
concentration and/or the recording time. A representative example of one of these 
recordings is shown in Fig. 7a (thick grey trace), that is compared to the much faster kinetics 
of F50/5 recordings (one example is in Fig. 7b, thick grey trace). This strong difference of 
permeabilization kinetics is better evidenced numerically by the 32-fold larger value of τa 
and τd of the CM15 recordings in respect to the F50/5 ones (Table 2), obtained by the 
monoexponential fittings to the activation and deactivation phases of both recordings 
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Fig. 7. Comparison of the kinetics parameters and the voltage dependence of the currents 
elicited by CM15 and F50/5. a, the fifth CM15 exposure of Fig. 6a (the time scale follows the 
one of Fig. 6a) is enlarged and the activation and deactivation of the current are fitted with 
monoexponential curves, which time constants are τa~14 s and τd ~9.1 s, respectively. The 
first two seconds of this trace is further enlarged in c, starting with the time in which the 
peptide was applied (at ~438 s from the beginning of recording of Fig. 6a), to show how Da 
was measured (indicated by the arrow, Da~1 s). b, the second F50/5 exposure of Fig. 6b (the 
time scale follows the one of Fig. 6b) is enlarged and the activation and deactivation of the 
current are fitted with monoexponential curves which time constants are τa~0.22 s and τd 
~0.36 s, respectively. The first 350 ms of this trace is enlarged in e, starting with the time in 
which the peptide was applied (at ~39 s from the beginning of recording of Fig. 6b); Da~0.21 
s (indicated by the arrow). d, voltage dependence of the current elicited by CM15 (thick grey 
trace) and by F50/5 (thin black trace) subtracted from the leakage, that was measured by 
applying the same voltage ramp in the absence of peptide (thick black trace). Dd was 
measured for both CM15 and F50/5 with the same procedure shown in c and e. Dotted lines 
in a and b indicate the zero current before peptide application. 
(shown in Fig. 7a and b, black traces). As expected, the average value of Da (Table 2) 
measured from the CM15 recordings on a fast time scale (indicated by the arrow in Fig. 7c) 
was larger than Da of F50/5 (Table 2; Fig. 7e). Moreover, Dd was not measurable in the case 
of F50/5 (since the current started to decrease as soon as the solution change was 
completed), while it was significant in the case of CM15 (Table 2). The dramatically slower 
kinetics parameters of CM15 in respect to F50/5 ones, indicate that it takes a longer time to  
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Parameter CM15 (n=6) F50/5 (n=10) L-Glu(OMe)7,18,19 (n=9) 
Da (s) 0.8±0.2 0.21±0.03 1.7±0.4 
a (s) 8.4±1.4 0.26±0.02 4.1±0.8 
Imax (nA) 0.51±0.05 0.70±0.03 0.74±0.20 
Dd (s) 0.6±0.2 0 0 
d (s) 10±2 0.31±0.02 1.9±0.6 
Table 2. Kinetics parameters of current elicited by CM15, F50/5, and L-Glu(OMe)7,18,19. 
form pores with CM15 monomers than with F50/5 (i.e. Da and τa of the CM15 are larger than 
the ones of F50/5). Moreover, once formed, the CM15 pores are more difficult to be 
disaggregated upon ceasing the peptide supply at the external solution (Dd and τd of CM15 
are again larger than the corresponding values measured for F50/5). In general, as Imax and 
the plateau amplitude following peptide removal progressively increased with repetitive 
CM15 applications, Da and τa progressively decreased while Dd and τd progressively 
increased. It is conceivable that the CM15 monomers build up in several regions of the OS 
membrane to a concentration not enough large to give rise to conductive pores: these 
peptides may then contribute in forming new pores once the CM15 is applied again 
extracellularly, giving rise to the observed acceleration of activation kinetics of the current 
(i.e. decreasing Da and τa). As expected, the resulting progressive build up of the number of 
conductive channels upon repeating the CM15 applications (that produced the progressive 
increase of Imax), would slow down more and more the deactivation kinetics (i.e. increasing 
Dd and τd), since larger the number of channels (that are also more stable than the ones 
produced by F50/5), longer it takes to disaggregate them when ceasing the CM15 supply 
from the external solution. Collectively, all data presented so far exclude a barrel and stave 
model of pore formation of CM15, while they strongly support this model of permeation in 
the case of the F50/5. Moreover, the cell integrity and the substantial recovery of current, 
observed for CM15 applications and withdrawal at concentrations as high as 10 µM (data 
not shown), exclude the carpet mechanism of membrane permeabilization at concentrations 
smaller than 10 µM, because micellation would produce the irreversible disruption of the 
membrane and cell lyses. It is however conceivable that, at high concentrations, CM15 could 
irreversibly permeabilize the membrane, by producing micellation according to the 
mechanism described in Fig. 1f. It therefore can be concluded that CM15 permeabilizes the 
membrane according to a toroidal model of pore formation. This view is also supported by 
the voltage-independency of CM15 membrane permeabilization, in contrast to F50/5, that 
instead inserts in the OS membrane at negative voltages (Vedovato et al., 2007; Vedovato & 
Rispoli, 2007a; Fig. 7d). Indeed, CM15 application at +20 mV or -20 mV produced currents 
with similar Imax (and Da, Dd, τa, τd as well; Fig. 6a). However, the latter protocol is not 
suitable to assess the precise voltage dependency of the current, since the current 
progressively increases with repetitive applications of CM15 (note that the maximal current 
amplitude at +20 mV in Fig. 6a is larger in respect to the one recorded at -20 mV). To 
circumvent this problem, rapid voltage ramps (slope: 0.25 mV/ms) were applied during 
CM15 perfusion at Vh=-20 mV, once the current stabilized for a period at least as long as the 
ramp (400 ms). To avoid the loss of voltage control due to Ra at extreme voltages (-60 and 
+40 mV, where current may became very large), cells were selected to have currents of 
about 100-200 pA at Vh=-20 mV. The response to the voltage ramp during CM15 perfusion 
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was subtracted to the response to the same voltage ramp recorded in control conditions (i.e. 
in the absence of peptide; Fig. 7d, thick black trace) to obtain the current-to-voltage 
relationship corrected for the leakage (Fig. 7d, thick grey trace). Relationship was almost 
perfectly ohmic for physiological voltages, in all cells examined (n=6), in contrast with the 
strong inward rectification of the current-to-voltage relationship (corrected for the leakage) 
produced by F50/5 (Fig. 7d, thin black trace, n=16), obtained with the same voltage protocol 
used for CM15. Therefore, it is required a particular orientation of the F50/5 monomers 
(attained with the voltage) to form a conductive channel, while the CM15 monomers 
permeabilize the membrane regardless their orientation. This again supports the barrel and 
stave model for F50/5 and the toroidal model for CM15. 
It can be argued that the pore formation according to the toroidal model could be ascribed to 
the relative abundance of lysine and/or leucine in respect to other aminoacids present in the 
CM15 sequence. Alternatively, the CM15-induced permeabilization might be due to some 
aspecific effect produced by the interaction of one or more of its amino acids with some 
membrane protein/s. These possibilities were however ruled out because a random 
sequence of the CM15 amino acids, (as the scrambled CM15; Table 1), was not able to 
produce any permeabilization, even for repetitive applications at 10 µM concentration 
(lasting up to 3 min; n=3 OS; data not shown). Therefore, it is concluded that CM15 must be 
lined up in a precise sequence to produce efficient membrane permeabilization. 
3.3 F50/5 monomer assembling mechanism 
The barrel and stave model of pore formation requires that a certain number of peptide 
monomers binds together to form a functioning pore. The hydrophilic glutammine residues 
at positions 7, 18 and 19 of F50/5 are supposed to face the pore lumen and form hydrogen-
bonded rings, therefore they are expected to play a key role in channel formation. To 
examine the role of these residues in the pore formation, the amino acids in position 18 and 
19, or all of three, were substituted with a glutamic acid, in which a methyl ester group was 
linked to the carboxyl function in the γ position. Two synthetic analogs, [L-Glu(OMe)18,19] 
and [L-Glu(OMe)7,18,19], were examined by applying them to the OS with the same protocol 
used to study the F50/5. Surprisingly, 1 µM concentration of both analogs produced a 
current as large that induced by F50/5, showing that these residue substitutions do not 
prevent pore formation. However, while all the kinetics parameters and the noise of current 
elicited by [L-Glu(OMe)18,19] were undistinguishable by the ones of F50/5, Da and τa of 
current elicited by [L-Glu(OMe)7,18,19] were ~8-fold and ~16-fold, respectively, larger than 
those of F50/5 (Table 2): therefore, the kinetics of pore formation was fairly impaired in the 
latter analog, but not in the former, in respect to F50/5. Moreover, as the current developed, 
there was a much larger noise increase in respect to F50/5 (and [L-Glu(OMe)18,19]), 
indicating that [L-Glu(OMe)7,18,19] may form fewer channels, but with a larger single channel 
conductance, than those generated by F50/5. The latter peptide applied at 250 nM 
concentration on the OS produced single channel events of several amplitudes, being not a 
simple multiple of a fixed size. Analysis of traces displaying very few channels (as the one 
shown in Fig. 8c, upper panel) allowed to estimate the smallest average single channel size, 
that resulted of ~50±8 pS at -20 mV (3500 events averaged in 3 cells). As expected, the single 
channel events produced by [L-Glu(OMe)7,18,19] at concentration of ~250 nM, were much 
larger than the F50/5 ones. Many different event amplitudes were produced by [L- 
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Glu(OMe)7,18,19], and some were so fast that they were cut by the patch-clamp amplifier, 
even when filtering as high as 2 KHz (Fig. 8c, bottom panel, grey trace). Since the majority of 
the events were anyway much slower, in order to compare the single channel amplitude of 
[L-Glu(OMe)7,18,19] with the one of F50/5, these very fast events were usually cancelled out  
 
Fig. 8. Kinetics of OS membrane permeabilization induced by synthetic F50/5 and its [L-
Glu(OMe)7,18,19] analog. a, upper traces, timing of application and withdrawal of peptides at 1 
μM concentration; lower trace, the voltage-clamp, whole-cell current recordings from one OS 
perfused with F50/5 (thin trace) and with [L-Glu(OMe)7,18,19] (thicker trace). Asteriscs indicate 
the occurrence of the two –10 mV voltage pulses (superimposed to Vh=-20 mV), used to 
measure Rm, that was about 1 GΩ before, and 20 s after, peptide application in both OS. b, 
the whole-cell current recordings of a are smoothed to accurately measure the activation 
delay, indicated by the arrows, that is 0.17 s for F50/5 and 2.8 s for [L-Glu(OMe)7,18,19], 
computed from the solution change (that occurs at time 0 in this plot); the other kinetics 
parameters were, respectively: τa (0.21 s and 7.4 s), τd (0.29 s and 1.6 s), and Imax (700 pA and 
760 pA at Vh=-20 mV; see Table 2). c, upper panel, single channel events produced by F50/5; 
lower panel, left, channel activity produced by [L-Glu(OMe)7,18,19] low-pass filtered at 2 KHz 
(grey trace) and at 100 Hz (superimposed black trace). Right, cumulative current amplitude 
distribution. Both recordings of c have the same scales and Vh=-20 mV; continuous and dotted 
lines indicate the most probable single channel amplitudes and 0 pA, respectively. 
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upon low pass filtering the traces at 100 Hz (Fig. 8c, bottom panel, black trace). The 
distribution of current amplitudes (Fig. 8c, bottom panel, right) showed that the most 
probable amplitude was 310±30 pS (820 events, n=3), but events of smaller sizes (as 260 pS) 
were recorded as well. For both peptides, current bursts occurred at very irregular intervals, 
making it impossible to systematically investigate interval duration, and measure key 
parameters as the open probability and the average open and closed time of the channel 
levels. The range of single channel amplitudes indicates that a channel is probably formed 
by several peptides assembled together, and various configurations of the peptide assembly 
are possible, depending upon the voltage, the peptide concentration and the duration of 
peptide application. 
The slower kinetics of current activation formed by [L-Glu(OMe)7,18,19] may simply reflect 
the smaller probability to assemble such large conductance channels. Consistently with this 
view, single channel events were recorded after ~20 s of [L-Glu(OMe)7,18,19] application to 
the OS (Vh=-20 mV), instead of ~5 s as in the case of F50/5. Similarly to F50/5, the current 
fell to zero without any delay in respect to [L-Glu(OMe)7,18,19] removal time, therefore this 
analog also does not stably integrate into the plasma membrane. Moreover, the current-to-
voltage relationship of [L-Glu(OMe)7,18,19] was almost identical to the F50/5 one (shown in 
Fig. 7d, thin black trace). 
Incidentally, the fact that the current elicited by F50/5 and by its analogs fell from 
several hundreds of pA to the single channel level following a 4-fold reduction of 
peptide concentration, and that the peptide-elicited current fell to 0 within a few 
hundred of ms following peptide removal from the external solution (see, for example, 
Fig. 8a and c), indicate that the pore formation and disaggregation are very fast and 
cooperative events.  
For all peptide tested, the Da, Imax, τa, and τd recorded in symmetric Na+ were very similar to 
those reported in Table 2 (i.e., recorded in symmetric K+; data not shown). 
All the above findings show that F50/5 and its analog [L-Glu(OMe)7,18,19], although 
exhibiting a very different kinetics of pore formation, retain the poor cation selectivity and 
the voltage dependency, that are typical features of peptaibols. However, they cannot 
conclusively indicate whether the ion conduction occurs through a pore formed with several 
peptide monomers assembled together, or it occurs along the inner portion of a single α-
helices. The three dimensional structure of [L-Glu(OMe)7,18,19] at a resolution of 0.95 Å, 
resolved from the electron density maps obtained by using the synchrotron radiation, 
consisted of two crystallographically independent bent α-helices, just long enough to span 
the membrane, but that cannot conduct ions through the hole produced by their helical 
arrangement (Crisma et al., 2007). Therefore, to explain the above electrophysiological 
results, and in particular the large current obtained at 1 µM concentration of peptide and the 
occurrence of single channel events at low concentrations, it is concluded that the α-helices 
of F50/5 and its analogs assemble around a central pore that is able to conduct ions, 
according to the barrel and stave model (Fig. 1). The peptaibols constitute therefore the most 
ancestral form of ion channel, since all the voltage gated channels, the ligand gated channels 
and the gap junction found in all eukaryotic cells, are formed by several α-helices that pack 
together around a central ion conducting pore. 
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3.4 Viroporin permeabilization 
The experimental strategy described above to study antibiotic peptides, turned out to be 
very powerful to investigate also the molecular mechanism of membrane permeabilization 
induced by viroporins. One of the most dangerous viroporins for human health is the 97-
residues long poliovirus 2B, a non-structural protein required for effective viral replication, 
that has been implicated in cell membrane permeabilization during the late phases of 
infection. The experiments presented so far demonstrated that antimicrobial peptides 
comprising 15-20 residues are able to form membrane pores: it is then conceivable that a 
short domain of poliovirus 2B sufficed to generate membrane permeabilization. Therefore, it 
was assessed the pore-forming properties of three peptides about 20 amino acid -long of an 
overlapping library that spanned the complete viroporin sequence. No significant changes 
of current level and of Rm (Fig. 9a, grey trace) were induced by continuous perfusion of the 
22-residues peptide at the beginning of poliovirus 2B sequence (7 out of 7 OS; Table 1, 
residues indicated in red) or at its end (5 out of 5 OS; Table 1, residues indicated in green) 
lasting up to 100 s, for peptide concentrations up to 1 μM. Since the permeabilization 
induced by peptaibols was voltage-dependent (Fig. 7d), Vh was changed in a range between 
–60 and +60 mV so to exclude that the lack of permeabilization was due to an inappropriate 
Vh (Fig. 9a, grey traces). Concentrations as little as 33 nM of the peptide spanning 2B residues 
35–55, (indicated in blue in Table 1), sufficed instead to significantly permeabilize the OS, 
and 100 nM permeabilized the OS to a point that Rm decreased by three order of magnitude 
and became comparable to Ra (Fig. 9a, black trace and Fig. 9c; Table 3). This permeabilization 
process can be quantitatively described, besides by the Rm change, by the parameters Da 
(indicated by the arrow in the inset of Fig. 9b) and Imax (see paragraph 3.1). However, τd and 
Dd cannot be measured, because, at difference with peptaibols and CM15, no significant 
current recovery was observed upon removing this peptide from the external solution. 
Moreover, current increased during the peptide application following a curve that cannot be 
interpolated with a single (or even a multiple) exponential: therefore, as far as the viroporin 
is concerned, τa symbolizes the 10-90% activation time, defined as the time interval in which 
the peptide induced current goes from 10% to 90% of the steady-state amplitude. The 
kinetics parameters of poliovirus 2B permeabilization on OS (Table 3) were measured at 
Vh=-20 mV, so to compare them with the ones of the antibiotic peptides (Table 2). The 
current-to-voltage relationship with a voltage ramp from –60 to +60 mV, measured once the 
current was stable, was linear and it was similar to the one predicted by the Ohm’s law with 
a resistance equal to Rm (22 MΏ in Fig. 9d). 
This is consistent with the view that the peptide must permeabilize the eukaryotic cell with 
high efficacy, independently by the cell state (as its membrane potential). Larger the peptide 
concentration, shorter was Da, being as small as 0.5 s at 1 μM. However, at such high peptide 
concentration, Rm became smaller than Ra, then Rm could not be measured and the steady-
state amplitude was meaningless (these two parameters were therefore not reported in 
Table 3). The large values of Da and τa indicate that this peptide must interact with the lipids 
for a long time, in respect to peptaibols and CM15, in order to permeabilize the membrane. 
This suggests that the membrane permeabilization occurs initially according to a toroidal 
model of pore formation; then, as more and more pores are formed, adjacent pores may 
restrict a micelle, that could detach and moves to the water phase, leaving a permanent hole 
behind, according to the carpet model of pore formation. 
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Fig. 9. Kinetics of OS membrane permeabilization induced by three domains of 
poliovirus 2B. a, current recorded during a 75 s application of: 1 µM of a domain at the 
beginning (indicated in red in Table 1) and at the end (indicated in green) of the viroporin 
sequence (light grey trace), 33 nM (grey trace), and 100 nM (black trace) of the central 
domain (blue) of 2B sequence (Vh=-20 mV throughout the recording). The timing of 
peptide application is indicated by the black line above the recording but the 33 nM 
peptide application, which is indicated in grey. b, same traces as a, but smoothed to 
accurately measure Da (indicated by the arrow) and Imax, whose numerical values are 
reported in Table 2. Rm before peptide application was measured from the current 
amplitude at –20 mV (-9.5 pA, Rm= 2.1 GΩ, black trace; -27.0 pA, Rm=0.8 GΩ, grey trace; 
average: 1.8±0.9 GΩ, n=7). The Rm following peptide application was measured once the 
current attained steady-state by using short (0.74 s) and small (-10 mV) voltage pulses 
(indicated by the asterisks close to both traces) superimposed on Vh. At steady-state, Rm 
(22 MΩ) became comparable to Ra (12 MΩ) after the application of the central domain of 
poliovirus 2B (in blue in Table 1), whereas it did not change significantly after perfusion 
of 1 µM of either the other two domains (in red and in green in Table 1). c, current elicited 
by 100 nM of the central domain shown in a on a slower time scale. d, current (lower 
trace) elicited by a voltage ramp (top trace) from -60 mV to 60 mV (slope: 0.244 mV/ms; 
Vh=-20 mV) applied once the current attained the steady-state during perfusion with 33 
nM of the central domain. 
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Conc. (nM) Da (s) 10-90% (s) Imax (nA) Rm pre(G) Rm post (M) Ra (M) 
33 (n=3) 9.9±2.6 31.8±7.2 0.22±0.08 1.3±0.3 110±40 18±7 
100 (n=5) 5.2±0.7 25.0±1.7 1.0±0.3 2.0±0.8 29±14 17±8 
1000 (n=3) 0.5±0.2 --- --- 1.2±0.5 --- 18±8 
Table 3. Kinetics parameters of current elicited by poliovirus 2B at different concentrations.  
3.5 Pressure polishing procedure 
The permeabilizing domain of poliovirus 2B has been applied on the external side of the 
OS. However, the ideal experiment would be delivering this peptide intracellularly, with 
a controlled timing, via the patch pipette by a tube inserted in its lumen, that should be 
placed as close as possible to the pipette tip. However, the long tapered shape of the 
pipette shank make it very difficult to perfuse efficiently the cell with this strategy (Fig. 
3c). In the Methods is illustrated a further improvement of an existing technique widening 
the patch pipette shank, through the calibrated combination of heat and air pressure, that 
allowed to insert quartz or plastic tubes in the pipette lumen very close to its tip. Once the 
pipette was properly aligned with the filament (Fig. 3b), the box was closed and the air 
pressure and the filament heating were turned on and off for an appropriate time (to 
attain the desired pipette shape), with the three-way valve and the push-to-make switch, 
respectively. The shaping process of the pipette shank and of its tip was precisely 
followed using a calibration grating superimposed on the LCD monitor. The pipette 
shank geometry and its tip opening diameter could be finely controlled by adjusting: 1) 
the relative position of the pipette in respect to the filament, 2) the current intensity 
passing through the filament, 3) the duration of this current flow, 4) the pressure 
intensity, and 5) the duration of the pressure application while the current was flowing in 
the filament. In order to standardize the technique, the most efficient strategy found was 
to optimize the parameters 1), 2), and 4) and to keep them fixed throughout the pressure 
polishing process, while the third and the fifth parameters were left to be adjusted each 
time in order to obtain the desired shank profile and tip opening diameter. Long pressure 
applications (while the current was flowing in the filament), were used to obtain very 
enlarged shanks. If the pipette opening resulted too large for a given pressure duration, 
then its tip was heated again in the absence of pressure until the desired size was 
achieved; if it was instead too small, then that pressure duration was applied to pipettes 
pulled with larger tips. Therefore, by carefully regulating the duration of pressure and 
heating application, the pipette shank was widened as desired, while the tip opening 
diameter could be increased, decreased or left unchanged. 
Pressure polished pipettes increased the rate of molecular diffusion between the pipette 
and the cell interior, allowing to perfuse viroporins or their domains and small proteins, 
making it possible the “real time modulation” of a multitude of cellular processes as 
well, as the signal transduction cascades. However, proteogenic molecules stick to the 
glass tip to the point to prevent seal formation, therefore it is important to add them to 
the pipette solution to a later time, i.e. after the seal was attained. In general, it is 
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important to apply to the cytosol a particular molecule under test not at the beginning of 
the whole-cell recording, but to a desired later time. This goal can be realized by 
inserting in the pipette lumen pulled quartz tubes (or tubes fabricated with plastics that 
can be easily softened with a Bunsen flame, as polyethylene or polypropylene), filled 
with a solution containing the molecule under test. The latter can be ejected into the 
pipette solution with a pulse of pressure applied to the tube lumen. These tubes could be 
inserted very close to the tip of pipettes with a particularly enlarged shank (i.e. very 
close to the cell cytosol; Fig. 3d). Therefore, the molecules under test would be applied to 
the cell cytosol with a much shorter delay in respect to conventional pipettes (Fig. 3c), 
delay that can be up to ~70 s for a small protein (having a diffusion coefficient of ~10-6 
cm2 s-1; Benedusi et al., 2011). 
Another great advantage of the pressure polished pipettes is the strong reduction of Ra, 
since all the electrical resistance of these pipettes is given to the tip opening diameter and 
not also to the pipette shank. The pressure polished pipettes were thoughtfully tested on 
frog OS, because this is the most critical cell system among the ones tested. Indeed, to 
have reliably recordings from frog OS, it is necessary to use pipettes with a very small tip 
diameter (yielding therefore high Ra if fabricated with conventional methods) to avoid to 
break the OS, because they are very fragile (Fig. 2a, inset) and they are often soiled with 
retina debris and vitreous humor. For pipettes shown in Fig. 3d it resulted a 4-fold 
reduction of Ra in respect to the conventional ones (Benedusi et al., 2011). 
Surprisingly, the chosen borosilicate glass (see Methods) was extremely good at attaining 
tight seals on an extremely wide variety of cells (being isolated or inserted in small tissue 
fragment or slice), or on giant unilamellar vesicles of many different lipid composition, 
providing that the pipettes and the pressure polishing set-up were maintained dirt-free, 
the pipette was kept in the bath as little as possible (to avoid that cell debris soiled the tip 
while approaching the cell), and the membrane target was “pressure cleaned” by ejecting 
as fast as possible the pipette solution onto the cell. It was not therefore true, as 
commonly believed, that different types of glass work better on different cell types 
(Penner, 1995): when there was a failure at attaining a seal, it was because the patch 
pipette tip was soiled, and/or because the membrane target was contaminated with cell 
debris, connective tissue or other organic material, not because the glass type was 
inappropriate. The day-to-day variability in attaining the seal was therefore entirely due 
to the cell quality (soiled or too fragile to sustain the sealing process), not to some 
uncontrollable parameter in the pipette fabrication. Given the “sealing power” of the 
glass pipette mentioned above, the pressure polishing technique was optimized just for 
this glass type. 
4. Conclusion 
The controlled application and withdrawal of peptides on isolated photoreceptor rod 
outer segments, recorded with the whole-cell voltage-clamp technique, resulted a 
powerful method to investigate the dynamics of pore formation and disassembly of 
membrane-permeabilizing peptides (as antibiotic peptides and viroporins) under strict 
physiological conditions. Moreover, the patch pipettes fabricated with the pressure 
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polished technique, and used as described above, allowed to reduce of at least 4-fold the 
access resistance, to efficiently incorporate exogenous molecules in the cytosol especially via 
pulled quartz or plastic perfusion tubes, and to seal virtually on any natural or artificial 
phospholipid bilayer. The main results presented in this chapter can be summarized as 
follows: 
1. One µM of alamethicin F50/5 produced an inward rectifying current that activated 
exponentially with a time constant of ~300 ms to a steady-state amplitude of 0.7 nA 
within ~200 ms from peptide application; at low concentration the F50/5 produced 
single channel activity of most probable conductance of ~50 pS. The hydrophilic Gln 
residues at positions 7, 18 and 19 are not a key factor for pore formation, but [L-
Glu(OMe)7,18,19] analog produced larger pores (~300 pS), with a lower probability of 
formation than F50/5. All these peptides do not stably integrate into the plasma 
membrane and they form pores according to the barrel and stave model with a highly 
cooperative mechanism. 
2. The cecropin-melittin hybrid peptide CM15 produced voltage-independent 
permeabilization of OS; repetitive peptide applications at concentrations >2 µM caused 
the progressive increase of the steady-state current amplitude. No clear single-channel 
events were detected at low peptide concentrations, while at concentrations as high as 
10 µM the cell integrity was preserved and the permeabilization was substantially 
reversible. Collectively, these results indicate that CM15 inserts in the plasma 
membrane according to the toroidal mechanism of pore formation. 
3. A peptide spanning residues 35-55 of the poliovirus 2B produced irreversible 
membrane permeabilization, probably according to the carpet model, producing 
voltage-independent current at concentrations as low as 33 nM. 
All these simple peptides are therefore not only an ideal tool to develop new 
antimicrobial and antiviral drugs, but they are important to understand the biophysical 
properties of much more complex molecules as channels and transporter proteins. The 
large variability of their pore-forming properties make them a potential lead for the 
development of bioactive compounds. 
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